https://www.selleckchem.com/pr....oducts/apr-246-prima
Our review provides insight into the mechanisms involved in GC progression, which may provide a new point cut for the discovery of new diagnostic markers and therapeutic strategies. Immune related interferon regulatory factor 4 (IRF4) is a member of the IRF family, whereas the clinical significance and possible role of IRF4 in lung adenocarcinoma (LUAD) remains unclear. We aimed to investigate the role of IRF4 in predicting the prognosis of LUAD patients. Using The Cancer Genome Atlas (TCGA) database and our immunohistochemic
Like
Comment
Share
